Counselors in Uvalde, TX Accepting Medicare

16 Counselors found. Showing 1 - 16

Sabrina Marie Vera, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 129 Goldbeck St, Uvalde, TX 78801 Phone: 210-807-1457    Fax: 830-374-9605

Nikki Rodriguez, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 105 Barry St, Uvalde, TX 78801 Phone: 830-279-8068

Ms. Monica M. Lara, M.ED., LPC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 560 N High St, Uvalde, TX 78801 Phone: 830-278-0480

Cynthia Mccaleb, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 328 Crystal City Hwy, Uvalde, TX 78801 Phone: 830-278-4041

Erin Reva Hernandez, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 718 S Getty St, Uvalde, TX 78801 Phone: 830-591-2250

Olga C. Vera, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 200 Evans St, Uvalde, TX 78801 Phone: 830-278-7105

Ms. Melissa Pettit, LPC-S Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 124 Royal Lane, Ste A, Uvalde, TX 78801 Phone: 830-486-5426

Debbie Lynn Gonzalez Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 3170 S Us Hwy 83, Uvalde, TX 78801 Phone: 830-444-1557

Bianca Rhodes Spies, LPC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 328 Crystal City Hwy, Uvalde, TX 78801 Phone: 830-278-2501    Fax: 830-278-4041

Mr. Paul David Flores, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2 Leona Heights Drive, Uvalde, TX 78801 Phone: 830-261-8133

Mr. Juan Antonio Sandoval Jr., LCDCI Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1815 Garner Field Rd, Uvalde, TX 78801 Phone: 830-591-1822    Fax: 830-591-1826

Brianna Aurora Vazquez, MA, LPC-ASSOCIATE Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1815 Garner Field Rd, Uvalde, TX 78801 Phone: 830-591-1822    Fax: 830-591-1826

Mr. David Wayne Wheeler, LCDC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1815 Garner Field Rd, Uvalde, TX 78801 Phone: 830-591-1822    Fax: 830-591-1826

Mrs. Melissa A Cabralez, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 239 Marsh Ln, Uvalde, TX 78801 Phone: 830-279-8054

Cassandra Anne Ramirez Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1815 Garner Field Rd, Uvalde, TX 78801 Phone: 830-591-1822    Fax: 830-591-1826

Mrs. Marla Gay Box, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1022 Garner Field Rd, Uvalde, TX 78801 Phone: 830-279-4544    Fax: 830-876-9076

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Ceregene initiates enrollment and dosing in CERE-120 Phase 2b trial for Parkinson's disease

Ceregene, a biopharmaceutical company, announced today that it is progressing with enrollment and dosing in its CERE-120 Phase 2b multi-center, sham-surgery, double-blinded controlled trial in Parkinson's disease.

NextGen executes agreement with MKMG to deploy EHR solution

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Mount Kisco Medical Group, PC (MKMG) to deploy NextGen Ambulatory EHR (Electronic Health Record), NextGen Practice Management, and the NextGen Patient portal.

CytRx provides overview of clinical development programs, reports 2014 Q3 financial results

CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended September 30, 2014, and also provided an overview of recent accomplishments by and upcoming milestones for its clinical development programs.

Cell Therapeutics reports cardiac safety results from phase II trial of pixantrone in CHOP-R regimen

Cell Therapeutics, Inc. reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen. Called PIX203, the randomized trial compared CPOP-R directly to CHOP-R in the 1st line treatment of high risk patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL, NHL).

Read more Medical News

› Verified 2 days ago